Reduced microRNA-5572 in thyroid eye disease orbital fibroblasts promotes fibrosis by targeting F2RL2
Experimental Eye Research · 2025
DOI: 10.1016/j.exer.2025.110565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Eye Research, 2025. Verfasst von Linfeng He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, 415 Fengyang Road, Shanghai, China. Hauptthemen laut MEDLINE: MicroRNAs, Graves Ophthalmopathy, Fibroblasts, Gene Expression Regulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Shenkang Hospital Development Center.
Abstract (Originalsprache)
PURPOSE: To investigate the role of microRNA-5572 in the regulation of fibrosis in orbital fibroblasts (OFs) derived from patients with thyroid eye disease (TED). METHODS: Transcriptome sequencing was performed on orbital adipose/connective tissue from patients with mild TED (n = 4), moderate-to-severe TED (n = 4), and healthy controls (n = 4) to identify differences in RNA molecules. miRWalk predicted microRNAs potentially involved in TED fibrosis and identified binding sites between F2RL2 and microRNA-5572, which were subsequently verified by dual-luciferase reporter assay. OFs obtained from patients with TED and healthy control donors were cultured. Quantitative real-time PCR and western blot quantified RNA and protein expression. Immunofluorescence staining detected collagen Ⅰ and α-SMA in orbital adipose/connective tissue. RESULTS: MicroRNA-5572 expression was down-regulated in TED-OFs compared with control OFs (CON-OFs). Functional experiments revealed that microRNA-5572 regulated COL1A1 expression in TED-OFs. Inhibiting microRNA-5572 increased COL1A1 protein expression. Furthermore, microRNA-5572 exerted this regulatory effect in TED-OFs by directly targeting F2RL2. CONCLUSIONS: MicroRNA-5572 was down-regulated in TED-OFs. Downregulation of microRNA-5572 directly targets F2RL2, thereby increasing COL1A1 expression in TED-OFs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, 415 Fengyang Road, Shanghai, China.
- Department of Anesthesiology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, 415 Fengyang Road, Shanghai, China.
- Department of Otolaryngology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, 415 Fengyang Road, Shanghai, China. Electronic address: 68109633@qq.com.
- Department of Ophthalmology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, 415 Fengyang Road, Shanghai, China. Electronic address: ruiliwei@126.com.
- Department of Ophthalmology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, 415 Fengyang Road, Shanghai, China. Electronic address: moupei@163.com.
Förderung
- National Natural Science Foundation of China
- Shanghai Shenkang Hospital Development Center
Zitieren
APA
He, L., Zhang, Y., Song, G., Ge, Q., Wei, R., & Mou, P. (2025). Reduced microRNA-5572 in thyroid eye disease orbital fibroblasts promotes fibrosis by targeting F2RL2. Experimental Eye Research. https://doi.org/10.1016/j.exer.2025.110565
Vancouver
He L, Zhang Y, Song G, Ge Q, Wei R, Mou P. Reduced microRNA-5572 in thyroid eye disease orbital fibroblasts promotes fibrosis by targeting F2RL2. Experimental Eye Research. 2025. doi:10.1016/j.exer.2025.110565
BibTeX
@article{He2025,
author = {He, Linfeng and Zhang, Yun and Song, Guoge and Ge, Qinghua and Wei, Ruili and Mou, Pei},
title = {Reduced microRNA-5572 in thyroid eye disease orbital fibroblasts promotes fibrosis by targeting F2RL2},
journal = {Experimental Eye Research},
year = {2025},
doi = {10.1016/j.exer.2025.110565}
}
EUVIMED